| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| June 18, 2026 | ±4.8% | -18.0% | under-priced |
| March 19, 2026 | ±3.3% | +4.3% | under-priced |
| December 18, 2025 | ±2.5% | -1.4% | over-priced |
| June 20, 2025 | ±1.8% | -6.9% | under-priced |
| March 20, 2025 | ±2.1% | -7.3% | under-priced |
| December 19, 2024 | ±2.0% | +7.1% | under-priced |
| June 20, 2024 | ±2.3% | +7.3% | under-priced |
| March 21, 2024 | ±1.9% | -9.3% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $3.80 | $18.7B | $2.3B |
| Q2 FY2026 | $2.93 | $18.0B | $1.8B |
| Q1 FY2026 | $3.54 | $18.7B | $2.2B |
| Q4 FY2025 | $2.25 | $17.6B | $1.4B |
Accenture PLC (ACN) reports in 73 days, with the next report estimated for October 9, 2026. Across the last 8 reports, options priced an average ±2.6% earnings move while the stock actually moved 7.7% on average — the market has tended to under-price ACN's earnings risk. Fundamentals into the print: EPS up 8.9% year-over-year, revenue up 5.6%. QuantLogix's live 5-factor engine currently reads ACN as a neutral at 52/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →